Integras Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28M Buy
35,784
+418
+1% +$36.6K 1.81% 22
2026
Q1
$3.01M Buy
35,366
+1,796
+5% +$160K 1.98% 25
2025
Q4
$2.65M Buy
33,570
+611
+2% +$47.9K 2.14% 25
2025
Q3
$2.63M Buy
32,959
+3,109
+10% +$265K 2.13% 26
2025
Q2
$2.71M Sell
29,850
-180
-0.6% -$16.4K 2.73% 15
2025
Q1
$2.81M Buy
30,030
+1,471
+5% +$132K 2.54% 16
2024
Q4
$2.6M Buy
+28,559
New +$2.73M 2.22% 19

Other funds holding CL

Integras Partners's CL Position: Q2 2026 in Review

Integras Partners increased its Colgate-Palmolive (CL) stake by 1.2% in Q2 2026, buying an estimated $36.6K and bringing the position to 35,784 shares worth $3.28M. The position accounts for 1.81% of the portfolio, ranked #22.

Integras Partners first reported a position in CL in Q4 2024 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Integras Partners held 35,784 shares of Colgate-Palmolive worth $3.28M as of Q2 2026.
  • Integras Partners bought 418 Colgate-Palmolive shares in Q2 2026, an estimated $36.6K.
  • Colgate-Palmolive made up 1.81% of Integras Partners's portfolio in Q2 2026, its #22 holding.
  • Integras Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Integras Partners's 13F filing for Q2 2026, filed 24 Jul 2026.